{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:12Z","timestamp":1787032872541,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,15]]},"DOI":"10.7759\/cureus.82315","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T14:53:57Z","timestamp":1744728837000},"source":"Crossref","is-referenced-by-count":2,"title":["Autoimmune Hepatitis (AIH) Related to Drug-Induced Liver Injury (DILI) Due to Atorvastatin"],"prefix":"10.7759","author":[{"given":"Jaime","family":"Loeza-Su\u00e1rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Citlalli","family":"Garc\u00eda-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janely","family":"Hern\u00e1ndez-Mir\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Ram\u00edrez-Marcial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grissell Alejandra","family":"Valero-Gaona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2014.08.040","article-title":"Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study","volume":"46","author":"Licata A","year":"2014","unstructured":"Licata A, Maida M, Cabibi D, et al.. Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study. Dig Liver Dis. 2014, 46:1116-20. 10.1016\/j.dld.2014.08.040","journal-title":"Dig Liver Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.07.023","article-title":"Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing","volume":"56","author":"Bj\u00f6rnsson E","year":"2012","unstructured":"Bj\u00f6rnsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol. 2012, 56:374-80. 10.1016\/j.jhep.2011.07.023","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1240010","article-title":"Drug-induced liver injury associated with statins","volume":"29","author":"Russo MW","year":"2009","unstructured":"Russo MW, Scobey M, Bonkovsky HL. Drug-induced liver injury associated with statins. Semin Liver Dis. 2009, 29:412-22. 10.1055\/s-0029-1240010","journal-title":"Semin Liver Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez F","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, et al.. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999, 31:929-38. 10.1016\/s0168-8278(99)80297-9","journal-title":"J Hepatol"},{"key":"ref5","article-title":"LiverTox: clinical and research information on drug-induced liver injury","volume":"and","year":"2025","unstructured":"LiverTox. clinical and research information on drug-induced liver injury. National Institute of Diabetes and Digestive. 2025, and:2021-5.","journal-title":"National Institute of Diabetes and Digestive"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5740\/jaoacint.18-0200","article-title":"Atorvastatin: a review of analytical methods for pharmaceutical quality control and monitoring","volume":"102","author":"Kogawa AC","year":"2019","unstructured":"Kogawa AC, Pires AE, Salgado HR. Atorvastatin: a review of analytical methods for pharmaceutical quality control and monitoring. J AOAC Int. 2019, 102:801-9. 10.5740\/jaoacint.18-0200","journal-title":"J AOAC Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200308000-00014","article-title":"Autoimmune hepatitis revealed by atorvastatin","volume":"15","author":"Pelli N","year":"2003","unstructured":"Pelli N, Setti M, Ceppa P, Toncini C, Indiveri F. Autoimmune hepatitis revealed by atorvastatin. Eur J Gastroenterol Hepatol. 2003, 15:921-4. 10.1097\/00042737-200308000-00014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.132197","article-title":"Acute hepatic injury with atorvastatin: an unusual occurrence","volume":"46","author":"Vishwakarma P","year":"2014","unstructured":"Vishwakarma P, Nehra R, Kumar A. Acute hepatic injury with atorvastatin: an unusual occurrence. Indian J Pharmacol. 2014, 46:343-4. 10.4103\/0253-7613.132197","journal-title":"Indian J Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094557","article-title":"Immune-mediated drug-induced liver injury: immunogenetics and experimental models","volume":"22","author":"Gerussi A","year":"2021","unstructured":"Gerussi A, Natalini A, Antonangeli F, et al.. Immune-mediated drug-induced liver injury: immunogenetics and experimental models. Int J Mol Sci. 2021, 22:4557. 10.3390\/ijms22094557","journal-title":"Int J Mol Sci"},{"key":"ref10","article-title":"Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry","volume":"106","author":"Perdices EV","year":"20141","unstructured":"Perdices EV, Medina-C\u00e1liz I, Hernando S, et al.. Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry. Rev Esp Enferm Dig. 20141, 106:246-54.","journal-title":"Rev Esp Enferm Dig"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116049","article-title":"Challenges and future of drug-induced liver injury research\u2014laboratory tests","volume":"23","author":"Weber S","year":"2022","unstructured":"Weber S, Gerbes AL. Challenges and future of drug-induced liver injury research\u2014laboratory tests. Int J Mol Sci. 2022, 23:6049. 10.3390\/ijms23116049","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.02.024","article-title":"Drug induced liver injury and its relationship to autoimmune hepatitis","volume":"55","author":"Weiler-Normann C","year":"2011","unstructured":"Weiler-Normann C, Schramm C. Drug induced liver injury and its relationship to autoimmune hepatitis. J Hepatol. 2011, 55:747-9. 10.1016\/j.jhep.2011.02.024","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v6.i4.160","article-title":"Drug-induced autoimmune liver disease: a diagnostic dilemma of an increasingly reported disease","volume":"6","author":"Castiella A","year":"2014","unstructured":"Castiella A, Zapata E, Lucena MI, Andrade RJ. Drug-induced autoimmune liver disease: a diagnostic dilemma of an increasingly reported disease. World J Hepatol. 2014, 6:160-8. 10.4254\/wjh.v6.i4.160","journal-title":"World J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e31828e5bfb","article-title":"Statins as a potential risk factor for autoimmune diseases: a case report and review","volume":"21","author":"John SG","year":"2014","unstructured":"John SG, Thorn J, Sobonya R. Statins as a potential risk factor for autoimmune diseases: a case report and review. Am J Ther. 2014, 21:e94-6. 10.1097\/MJT.0b013e31828e5bfb","journal-title":"Am J Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki A","year":"2011","unstructured":"Suzuki A, Brunt EM, Kleiner DE, et al.. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology. 2011, 54:931-9. 10.1002\/hep.24481","journal-title":"Hepatology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/340259-autoimmune-hepatitis-aih-related-to-drug-induced-liver-injury-dili-due-to-atorvastatin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T14:53:58Z","timestamp":1744728838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/340259-autoimmune-hepatitis-aih-related-to-drug-induced-liver-injury-dili-due-to-atorvastatin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.82315","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,15]]}}}